Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
CONCLUSION: Serum chitotriosidase may be a potential biomarker for predicting a poor prognosis in patients with anti-MDA5-positive DM/CADM-ILD.
PMID: 31092718 [PubMed - as supplied by publisher]
Source: Journal of Rheumatology - Category: Rheumatology Tags: J Rheumatol Source Type: research
More News: Dermatology | Dermatomyositis | Genetics | Interstitial Lung Disease | Laboratory Medicine | Polymyositis | Respiratory Medicine | Rheumatology | Study